bioXXmed Beheer
Beheer criteriumcontroles 0/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Mark-André Freyberg
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 24.8yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Geen updates
Recent updates
CEO
Mark-André Freyberg
24.8yrs
Tenure
Dr. Mark-Andr? Freyberg co-founded bioXXmed AG (formerly known as CytoTools AG) in 2000 and serves as Chief Executive Officer since 2000 and had been the Chairman of Management Board until September 30, 20...